<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Singh M</submitter><funding>Ministry of Education, Culture, Sports, Science, and Technology</funding><pagination>e01154-16</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5278750</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>61(2)</volume><pubmed_abstract>The mechanisms underlying bacterial tolerance to antibiotics are unclear. A possible adaptation strategy was explored by exposure of drug-naive methicillin-susceptible Staphylococcus aureus strain FDA209P to vancomycin in vitro Strains surviving vancomycin treatment (vancomycin survivor strains), which appeared after 96 h of exposure, were slow-growing derivatives of the parent strain. Although the vancomycin MICs for the survivor strains were within the susceptible range, the cytokilling effects of vancomycin at 20-fold the MIC were significantly lower for the survivor strains than for the parent strain. Whole-genome sequencing demonstrated that ileS, encoding isoleucyl-tRNA synthetase (IleRS), was mutated in two of the three vancomycin survivor strains. The IleRS Y723H mutation is locate</pubmed_abstract><journal>Antimicrobial agents and chemotherapy</journal><pubmed_title>In Vitro Tolerance of Drug-Naive Staphylococcus aureus Strain FDA209P to Vancomycin.</pubmed_title><pmcid>PMC5278750</pmcid><funding_grant_id>S1201013</funding_grant_id><pubmed_authors>Hishinuma T</pubmed_authors><pubmed_authors>Morimoto Y</pubmed_authors><pubmed_authors>Singh M</pubmed_authors><pubmed_authors>Sasaki T</pubmed_authors><pubmed_authors>Matsuo M</pubmed_authors><pubmed_authors>Hiramatsu K</pubmed_authors></additional><is_claimable>false</is_claimable><name>In Vitro Tolerance of Drug-Naive Staphylococcus aureus Strain FDA209P to Vancomycin.</name><description>The mechanisms underlying bacterial tolerance to antibiotics are unclear. A possible adaptation strategy was explored by exposure of drug-naive methicillin-susceptible Staphylococcus aureus strain FDA209P to vancomycin in vitro Strains surviving vancomycin treatment (vancomycin survivor strains), which appeared after 96 h of exposure, were slow-growing derivatives of the parent strain. Although the vancomycin MICs for the survivor strains were within the susceptible range, the cytokilling effects of vancomycin at 20-fold the MIC were significantly lower for the survivor strains than for the parent strain. Whole-genome sequencing demonstrated that ileS, encoding isoleucyl-tRNA synthetase (IleRS), was mutated in two of the three vancomycin survivor strains. The IleRS Y723H mutation is locate</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Feb</publication><modification>2026-05-05T07:40:08.913Z</modification><creation>2019-03-27T02:35:14Z</creation></dates><accession>S-EPMC5278750</accession><cross_references><pubmed>27855063</pubmed><doi>10.1128/AAC.01154-16</doi></cross_references></HashMap>